Insider · CIK 0001329154
Mark J Rosenblum
Files at DCOY (Salarius Pharmaceuticals, Inc.). First filing Nov 20, 2025, latest Nov 20, 2025.
Mark J Rosenblum files SEC Form 4 as CFO at DCOY (Salarius Pharmaceuticals, Inc.). Since Nov 20, 2025, Mark J Rosenblum has reported 1 open-market buy worth $16k and 0 open-market sells worth $0, the latest filed on Nov 20, 2025.
A track record needs three past buys with six months of prices behind them; Mark J Rosenblum has 0, so none is measured yet.
The newest scored trade: bought $16k of DCOY on Nov 20, 2025, filed Nov 20, 2025, scored 40 (moderate). In the last 12 months: 1 buy worth $16k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DCOY: Salarius Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Salarius Pharmaceuticals, Inc. | $16k 20,000 shares | first purchase | - |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +9,682 | $0.00 | $0 | 11,363 | 41 d ago |
| Nov 20, 2025 | DCOY Salarius Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +20,000 | $0.80 | $16k | 20,177 | Nov 20, 2025 |
Questions about Mark J Rosenblum
Answered from the filings on this page, as of the latest one.
Is Mark J Rosenblum buying or selling?
In the last 12 months Mark J Rosenblum reported 1 open-market buy worth $16k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $16k of DCOY on Nov 20, 2025. Grants, option exercises and tax withholding are not counted.
How did Mark J Rosenblum's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark J Rosenblum has 0.
Where does Mark J Rosenblum file Form 4?
Mark J Rosenblum has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.) as Exec VP Finance, CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.